Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEA
551
Easterly Government Properties
DEA
$1.18B
| $34.6M | 0.03% |
599,192
-269,217
| -31% | -$17.1M |
|
552
Sonos
SONO
$1.96B
| $34.6M | 0.03% |
2,365,898
-344,900
| -13% | -$3.66M |
|
|
CKH
553
DELISTED
Seacor Holdings Inc.
CKH
| $34.6M | 0.03% |
1,221,705
-75,100
| -6% | -$2.05M |
|
|
WIFI
554
DELISTED
Boingo Wireless, Inc.
WIFI
| $34.5M | 0.03% |
2,589,900
+25,200
| +1% | +$330K |
|
|
BCPC
555
Balchem Corp
BCPC
$5.65B
| $34.4M | 0.03% |
362,508
+122,800
| +51% | +$11.5M |
|
556
Enova International
ENVA
$6.52B
| $34.2M | 0.03% |
2,298,118
-105,976
| -4% | -$1.47M |
|
557
Gibraltar Industries
ROCK
$1.45B
| $34.1M | 0.03% |
709,700
+83,296
| +13% | +$3.7M |
|
|
SGI
558
Somnigroup International
SGI
$14B
| $34M | 0.03% |
1,891,584
-314,000
| -14% | -$4.5M |
|
559
Universal Corp
UVV
$1.12B
| $34M | 0.03% |
798,811
+87,200
| +12% | +$3.84M |
|
|
PRO
560
DELISTED
PROS Holdings
PRO
| $33.9M | 0.03% |
764,000
-336,900
| -31% | -$11.9M |
|
561
StoneCo
STNE
$2.49B
| $33.9M | 0.03% |
874,400
+845,900
| +2,968% | +$24.7M |
|
562
Globus Medical
GMED
$11.5B
| $33.9M | 0.03% |
710,314
-634,400
| -47% | -$30.6M |
|
563
Camden Property Trust
CPT
$11.1B
| $33.8M | 0.03% |
370,900
+71,800
| +24% | +$6.35M |
|
564
Winmark
WINA
$1.26B
| $33.7M | 0.03% |
196,650
-11,600
| -6% | -$1.7M |
|
565
PACCAR
PCAR
$68.8B
| $33.4M | 0.03% |
668,967
-229,134
| -26% | -$10.7M |
|
|
BSTC
566
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $33.3M | 0.03% |
543,356
+3,200
| +0.6% | +$185K |
|
567
CoStar Group
CSGP
$13.4B
| $33.1M | 0.03% |
465,980
+366,980
| +371% | +$23.7M |
|
568
Middlesex Water
MSEX
$1.11B
| $33.1M | 0.03% |
492,800
-35,900
| -7% | -$2.27M |
|
569
Devon Energy
DVN
$48.8B
| $33M | 0.03% |
2,914,310
-1,702,782
| -37% | -$19.4M |
|
570
Marvell Technology
MRVL
$199B
| $33M | 0.03% |
+942,377
| New | +$27.6M |
|
|
LGTY
571
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $33M | 0.03% |
2,094,400
+71,700
| +4% | +$1.21M |
|
572
NRC Health Common Stock
NRC
$471M
| $33M | 0.03% |
566,500
-39,400
| -7% | -$2.08M |
|
573
Broadcom
AVGO
$1.99T
| $32.5M | 0.03% |
+1,029,960
| New | +$28.8M |
|
574
REX American Resources
REX
$1.44B
| $32.1M | 0.03% |
2,776,584
-115,800
| -4% | -$1.15M |
|
575
Yum! Brands
YUM
$41.2B
| $32.1M | 0.03% |
369,100
-94,803
| -20% | -$8.1M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.